newsfilter
← Latest News
GlobeNewswire·

Allarity Therapeutics Reports Full Year 2024 Financial Results and Provides a Business Update

Cash and cash receivable balance of $20.9 million as of December 31, 2024, expected to fund operations, including clinical activities into 2027Strengthened cash position expected to support the Company through